Skip to main content
Quest Diagnostics

Driving Knowledge to Action: Building a Better Future With Artificial Intelligence-Enabled Multidisciplinary Oncology

Driving Knowledge to Action: Building a Better Future With Artificial Intelligence-Enabled Multidisciplinary Oncology

Authors: Loaiza-Bonilla A, Thaker N, Chung C, Parikh RB, Stapleton S, Borkowski P

Citation: Am Soc Clin Oncol Educ Book. 2025 May 2:e100048. doi: 10.1200/EDBK-25-100048.

Specialties: Oncology

Related content

Audio Podcast
Exploring Digital Pathology and Artificial Intelligence
Publication
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms
Publication
Revolutionizing Digital Pathology With the Power of Generative Artificial Intelligence and Foundation Models
Conference Presentation
AI-Empowered Digital Workflow for Prostate Pathology in Clinical Routine: A Reader Study for Prostate Biopsies
Conference Presentation
Application of AI for the Interpretation of Real Time PCR assay in a High-Volume Clinical Laboratory

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.